PineBridge Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.07M | Buy |
5,071
+2,497
| +97% | +$490K | 0.01% | 422 |
|
|
2026
Q1 | $504K | Buy |
+2,574
| New | +$500K | ﹤0.01% | 439 |
|
|
2024
Q2 | – | Sell |
-22,801
| Closed | -$3.04M | – | 575 |
|
|
2024
Q1 | $3.04M | Buy |
22,801
+16,446
| +259% | +$2.13M | 0.02% | 385 |
|
|
2023
Q4 | $876K | Buy |
6,355
+2,686
| +73% | +$353K | 0.01% | 464 |
|
|
2023
Q3 | $447K | Sell |
3,669
-1,416
| -28% | -$189K | 0.01% | 537 |
|
|
2023
Q2 | $715K | Buy |
5,085
+4,772
| +1,525% | +$658K | 0.01% | 457 |
|
|
2023
Q1 | $44.3K | Sell |
313
-134
| -30% | -$19.2K | ﹤0.01% | 590 |
|
|
2022
Q4 | $69.9K | Sell |
447
-85,720
| -99% | -$12.3M | ﹤0.01% | 538 |
|
|
2022
Q3 | $10.6M | Sell |
86,167
-39,820
| -32% | -$5.24M | 0.14% | 178 |
|
|
2022
Q2 | $16.8M | Buy |
125,987
+27,071
| +27% | +$3.69M | 0.21% | 132 |
|
|
2022
Q1 | $13.5M | Buy |
98,916
+81,873
| +480% | +$11.4M | 0.15% | 167 |
|
|
2021
Q4 | $2.95M | Sell |
17,043
-23,263
| -58% | -$3.54M | 0.03% | 366 |
|
|
2021
Q3 | $5.86M | Sell |
40,306
-32,845
| -45% | -$4.81M | 0.07% | 261 |
|
|
2021
Q2 | $9.65M | Buy |
73,151
+1,265
| +2% | +$166K | 0.11% | 209 |
|
|
2021
Q1 | $9.23M | Buy |
71,886
+10,597
| +17% | +$1.31M | 0.12% | 210 |
|
|
2020
Q4 | $7.3M | Buy |
+61,289
| New | +$7.47M | 0.11% | 214 |
|
|
2019
Q2 | – | Sell |
-78,230
| Closed | -$7.04M | – | 1102 |
|
|
2019
Q1 | $7.04M | Sell |
78,230
-15,051
| -16% | -$1.3M | 0.14% | 168 |
|
|
2018
Q4 | $7.77M | Buy |
93,281
+82,732
| +784% | +$7.76M | 0.17% | 159 |
|
|
2018
Q3 | $1.14M | Buy |
+10,549
| New | +$1.16M | 0.02% | 561 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$10K | – | 1093 |
|
|
2018
Q1 | $10K | Sell |
100
-5,413
| -98% | -$554K | ﹤0.01% | 1082 |
|
|
2017
Q4 | $543K | Buy |
+5,513
| New | +$523K | 0.01% | 797 |
|
|
2017
Q1 | – | Sell |
-140
| Closed | -$13K | – | 1135 |
|
|
2016
Q4 | $13K | Buy |
+140
| New | +$12.1K | ﹤0.01% | 1153 |
|
|
2016
Q1 | – | Sell |
-335
| Closed | -$24K | – | 1126 |
|
|
2015
Q4 | $24K | Buy |
335
+7
| +2% | +$471 | ﹤0.01% | 1038 |
|
|
2015
Q3 | $20K | Buy |
+328
| New | +$22.9K | ﹤0.01% | 1068 |
|
|
2015
Q1 | – | Sell |
-65,765
| Closed | -$4.41M | – | 1103 |
|
|
2014
Q4 | $4.41M | Sell |
65,765
-3,929
| -6% | -$248K | 0.17% | 152 |
|
|
2014
Q3 | $4.23M | Sell |
69,694
-111,931
| -62% | -$6.9M | 0.17% | 143 |
|
|
2014
Q2 | $10.7M | Sell |
181,625
-66,643
| -27% | -$3.9M | 0.42% | 78 |
|
|
2014
Q1 | $14.4M | Buy |
248,268
+84,674
| +52% | +$4.54M | 0.47% | 71 |
|
|
2013
Q4 | $8.76M | Buy |
163,594
+52,074
| +47% | +$3.09M | 0.26% | 114 |
|
|
2013
Q3 | $6.89M | Buy |
111,520
+23,254
| +26% | +$1.39M | 0.21% | 134 |
|
|
2013
Q2 | $5.35M | Buy |
+88,266
| New | +$5.26M | 0.17% | 152 |
|
Other funds holding DGX
EIG
PineBridge Investments's DGX Position: Q2 2026 in Review
PineBridge Investments increased its Quest Diagnostics (DGX) stake by 97% in Q2 2026, buying an estimated $490K and bringing the position to 5,071 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #422.
PineBridge Investments first reported a position in DGX in Q2 2013 and has held it in 31 quarters since. The position peaked at $16.8M in Q2 2022. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- PineBridge Investments held 5,071 shares of Quest Diagnostics worth $1.07M as of Q2 2026.
- PineBridge Investments bought 2,497 Quest Diagnostics shares in Q2 2026, an estimated $490K.
- Quest Diagnostics made up 0.01% of PineBridge Investments's portfolio in Q2 2026, its #422 holding.
- PineBridge Investments first reported a position in Quest Diagnostics in Q2 2013 and has held it in 31 quarters since.
- PineBridge Investments's Quest Diagnostics position peaked at $16.8M in Q2 2022.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on PineBridge Investments's 13F filing for Q2 2026, filed 14 Aug 2026.